Oct 24, 2019 8:21 AM
BACK TO TOP
KSE 100
33,439.69
240.73
(0.73%)
KSE ALL
24,304.12
209.64
(0.87%)
KSE 30
15,616.11
128.88
(0.83%)
KMI 30
54,092.83
589.96
(1.10%)
KMI ALL
15,842.84
148.45
(0.95%)
GlaxoSmithKline Pakistan Limited
PHARMACEUTICALS
Rs.103.88
0.93
(0.90%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Wed, Oct 23, 2019 3:34 PM
REG
FUT
ODL
Open
104.80
High
105.10
Low
103.50
Volume
21,600
CIRCUIT BREAKER
97.81 — 108.09
DAY RANGE
103.50 — 105.10
52-WEEK RANGE
81.55 — 152.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
102.95
VAR
11.00
HAIRCUT
31.50
P/E Ratio (TTM)
11.80
1-Year Change *
-20.93%
YTD Change *
-7.81%
Open
107.00
High
110.00
Low
105.01
Close
110.00
Change
6.85%
LDCP
102.95
Volume
9
Total Trades
5
CIRCUIT BREAKER
92.66 — 113.24
DAY RANGE
105.01 — 110.00
Ask Price
113.23
Ask Volume
5
Bid Price
105.00
Bid Volume
2
Market data powered by capitalstake.com. Provided by PSX.* Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

GlaxoSmithKline Pakistan Limited (the Company) is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).

KEY PEOPLE
Mr Andrew AristidouChairman
Mr. M. Azizul HuqCEO
Mr. Syed Azeem Abbas NaqviCompany Secretary
ADDRESS

35 - Dockyard Road, West Wharf, Karachi

WEBSITE

www.gsk.com.pk

REGISTRAR

Central Depository Company of Pakistan Limited. CDC House, 99-B, Block-B, S.M.C.H.S., Main Shahrah-e-Faisal, Karachi

AUDITOR

Deloitte Yousuf Adil & Co. Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
33,082,380.84
Shares
318,467,278
Free Float
51,704,105
Free Float
16.24%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Aug 29, 2019Transmission of Quarterly Report for the Period Ended June 30, 2019 View   PDF
Aug 28, 2019Financial Results for the Half Year Ended June 30, 2019 View   PDF
Apr 30, 2019Transmission of Quarterly Report for the Period Ended March 31, 2019 View   PDF
Apr 24, 2019Financial Results for the quarter ended March 31, 2019 View   PDF
Apr 3, 2019Transmission of Annual Report for the year ended 2018-12-31 View   PDF
Mar 4, 2019Financial Results for the Year Ended December 31, 2018 View   PDF
Oct 30, 2018Transmission of Quarterly Report for the Period Ended 30 September 2018 View   PDF
Oct 29, 2018Financial Results for the Quarter Ended 30 September 2018 View   PDF
Aug 28, 2018ransmission of Quarterly Report for the Period Ended 30 Jun 2018 View   PDF
Aug 13, 2018Financial Results for the Quarter Ended 30 June 2018 View   PDF
DateTitleDocument
Oct 21, 2019Board Meeting View   PDF
Aug 21, 2019Board of Directors Meeting View   PDF
Jun 19, 2019Board Meeting Other Than Financial Results View   PDF
Jun 12, 2019GSK Pakistan Limited - Board of Directors Meeting - Other Than Financial Results View   PDF
Apr 17, 2019Board of Directors Meeting View   PDF
Apr 3, 2019Notice of Annual General Meeting View   PDF
Feb 25, 2019Board of Directors Meeting - GlaxoSmithKline Pakistan Limited View   PDF
Oct 23, 2018Board Meeting View   PDF
Aug 6, 2018Board Meeting View   PDF
Apr 17, 2018Board Meeting First Quarter Mar 2018 View   PDF
DateTitleDocument
Sep 26, 2019Material Information View   PDF
Aug 28, 2019Change of Board Director of GSK Pakistan Limited View   PDF
May 15, 2019Notice of Credit of Final Cash Dividend in Newspapers View   PDF
May 14, 2019Credit of Final Cash Dividend View   PDF
May 14, 2019Publication - Notice of Direct Credit of Final Cash Dividend under regulation No. 5.6.4(b) of Rule Book of PSX View   PDF
Dec 31, 2018Material Information - GlaxoSmithKline Pakistan Limited View   PDF
Dec 10, 2018Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Dec 7, 2018Material Information View   PDF
Sep 11, 2018Material Information - Resignation of Mr. Husain Lawai, Independent Director and Chairman of the Audit Committee View   PDF
May 15, 2018Credit of Final Cash Dividend View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2018201720162015
Sales34,006,84032,773,77027,563,53323,821,926
Profit after Taxation3,257,9512,981,0232,762,1852,510,726
EPS10.239.368.688.30
Q2 2019Q1 2019Q3 2018Q2 2018
Sales9,285,4248,368,0518,049,9608,101,554
Profit after Taxation341,678532,910541,061415,574
EPS1.071.671.701.30
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2018201720162015
Gross Profit Margin (%)24.7426.4827.0826.97
Net Profit Margin (%)9.589.1010.0210.54
EPS Growth (%)9.297.834.5856.60
PEG1.192.295.870.47

Payouts

DateFinancial ResultsDetailsBook Closure
March 4, 2019 4:53 PM31/12/2018(YR) 70%(F) (D) 18/04/2019 - 24/04/2019
February 27, 2018 3:59 PM31/12/2017(YR) 40% (D) 18/04/2018 - 24/04/2018
October 26, 2017 5:47 PM30/09/2017(IIIQ) 30% (D) 10/11/2017 - 17/11/2017
March 8, 2017 4:03 PM31/12/2016(YR) 60% (D) 18/04/2017 - 24/04/2017
March 30, 2016 3:13 PM31/12/2015(YR) 40% (D) 20/04/2016 - 27/04/2016
February 25, 2015 3:51 PM31/12/2014(YR) 50% (D) 16/04/2015 - 23/04/2015
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014
February 7, 2014 3:24 PM31/12/2013(YR) 35% (D) - 10% (B) 21/04/2014 - 28/04/2014
February 18, 2013 2:37 PM31/12/2012(YR) 40% (F) (D) - 10% (B) 12/04/2013 - 18/04/2013
March 8, 2012 3:50 PM31/12/2011(YR) 40%(F) (D) - 10% (B) 30/03/2012 - 06/04/2012

Financial Reports